This article has been retracted: Oncotarget has completed its investigation of this paper. A concerned reader informed the journal of several instances of image duplication. Namely, there is internal duplication between two images in Figure 3C. In addition, two images in Figure 3C are duplicates of images in Figure 6F from a previously published paper [1]. There is also a second internal duplication of one image in both Figures 4B and 6B. In light of these issues, the journal requested clarification regarding these images from the authors. The provided explanations were deemed unacceptable by the Scientific Integrity Office. Based on these facts, Oncotarget has decided to retract this paper.
Original article: Oncotarget. 2016; 7:42844–42858. 42844-42858. https://doi.org/10.18632/oncotarget.10212
REFERENCES
- 1. Yoon C, Lee HJ, Park DJ, Lee YJ, Tap WD, Eisinger-Mathason TS, Hart CP, Choy E, Simon MC, Yoon SS. Hypoxia-activated chemotherapeutic TH-302 enhances the effects of VEGF-A inhibition and radiation on sarcomas. Br J Cancer. 2015; 113:46–56. 10.1038/bjc.2015.186. [DOI] [PMC free article] [PubMed] [Google Scholar]